What's a fair offer from Pfizer?, page-33

First 33 Last

Share
Profile

Follow
AlCp

26,812 Posts.

1738

12/04/22

23:30

Post #: 60818672
Share

Originally posted by mondyinvest ↑

Hi TT, as well as @aras, @AlCp and @MrAdem. Thanks for your responses.

I get where you are all coming from, but the original point still stands. ResApp may indeed have great future revenue prospects etc, but Pfizer aren't offering to buy them at some stage far in the future when all of that is realised - they are offering to buy them now: when RAP look like they have great tech, but no cash, and no way to quickly monetise the tech, and therefore no revenue.

Pfizer are offering a premium already far above what the rest of the sharemarket was willing to pay at this very point in time. I'm not saying it's perfectly fair, or that holders should be happy (quite the opposite - the SP is down here because progress has been so snail-like). But at the same time, the pragmatist in me can understand why ResApp management are sort of saying "well, if you think we're worth so much more than 11.5c a share *at this precise moment in time* then why haven't you bid up the price on-market prior to this deal breaking?"

Not here to sledge, as I said the fact Pfizer want to buy it appears to be a great endorsement - but expectations seem totally out of whack with reality. PS: I say all of this as someone who only invests - I buy and hold, I don't trade.

Expand

$1 T/O bid is way over and 11.5c is consider very under by LT......interesting time and when has management question the current value of the MC given LT in the top 20 haven't sold as we know the market potential of ResAppDx-EU which has just started to gain traction in revenue????

RAP Price at posting: 11.5¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Bitcoin investors need to know the risks

There are more pages in this discussion • 9 more messages in this thread...

First 33 Last

Add RAP (ASX) to my watchlist

What's a fair offer from Pfizer?, page-33

Top Stories

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Nimy to raise $1.21M to explore 'newsy' WA targets

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

Immutep reports strong response rate from immunotherapies treating carcinomas

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Bitcoin investors need to know the risks

Featured News